Venture Management

Immuto Scientific is a biotechnology services company that specializes in providing analytical insights to pharmaceutical firms involved in drug discovery. The company has developed a protein footprinting technology that automates complex protein analysis, significantly enhancing the efficiency of the drug development process for protein therapeutics. This technology offers a faster alternative to traditional methods for protein structure analysis, allowing drug developers to determine protein structures more quickly and effectively, thereby streamlining the overall drug discovery process.

AIQ Solutions, Inc. specializes in the development of medical devices and software solutions aimed at the quantitative assessment of lesions related to complex diseases, primarily cancer. The company's clinical decision support platform analyzes medical imaging data to identify and quantify all lesions in cancer patients, tracking changes post-treatment. AIQ Solutions offers innovative products such as quantitative total bone imaging (QTBI), which provides insights into metastatic bone disease, and quantitative total marrow imaging (QTMI), which assesses disease heterogeneity and treatment response in bone marrow. Founded in 2015 and based in Madison, Wisconsin, the company emerged from the University of Wisconsin Translational Imaging Research Program, with its founders possessing extensive experience in drug development and clinical trials. AIQ Solutions has received FDA 510(k) clearance for its QTxI platform, reinforcing its commitment to enhancing patient management and outcomes in oncology. Its products serve oncologists, radiologists, nuclear medicine physicians, and pharmaceutical companies.

HealthMyne, Inc. is a healthcare informatics company based in Madison, Wisconsin, established in 2013. It specializes in providing innovative imaging solutions and analytics primarily for cancer care providers. The company's technology enhances clinical decision-making by offering real-time, evidence-based imaging insights that facilitate improved patient care while also reducing delivery costs. HealthMyne's platform includes features such as tumor image manipulation, automatic tumor staging, specialized reporting, and management of incidental findings, all aimed at streamlining clinical workflows. By integrating electronic health records and image repositories, HealthMyne supports physicians in diagnosing and treating patients more effectively, ultimately enhancing clinical collaboration and quality assurance in patient management.

Swallow Solutions, LLC is a company based in Madison, Wisconsin, dedicated to addressing swallowing disorders, also known as dysphagia, in the United States. Established in 2004, the company specializes in therapeutic devices designed for the diagnosis and treatment of swallowing difficulties, along with nutritional food products tailored to the specific needs of patients based on their condition. One of its primary offerings is SwallowSTRONG, which includes a custom-molded mouthpiece and accompanying software that aids speech language pathologists in implementing evidence-based therapy to strengthen the tongue. Additionally, the SwallowSTRONG Management System is a cloud-based platform that allows clinicians to monitor patient progress remotely, adjust therapy parameters as needed, and access therapy data for analysis and reporting. Through these innovative solutions, Swallow Solutions aims to enhance the health and well-being of individuals with dysphagia.

Carson Life, Inc. is a manufacturer and supplier of natural health and beauty products, with a focus on the Hispanic market. Founded in 2014 and based in Miami, Florida, the company offers a diverse range of products, including those for weight loss, hair care, skin care, anti-aging, and vitamins. Carson Life has established exclusive endorsement deals with prominent celebrities within the Hispanic community to enhance its brand appeal. Its products are available through more than 7,000 retail locations, including major chains like Walmart, Walgreens, HEB, Target, and CVS, as well as through its online webshop and e-commerce platforms such as Amazon. The company emphasizes sustainability and eco-friendliness in its offerings, providing customers with convenient options to subscribe and order products online, contributing to a lifestyle characterized by energy and confidence.

FluGen, Inc. is a biopharmaceutical company focused on the prevention and treatment of influenza and other respiratory pathogens. Founded in 2007 and based in Madison, Wisconsin, FluGen develops vaccines to combat seasonal and pandemic influenza. Its primary product, RedeeFlu, is a nasal spray vaccine designed to protect against influenza, utilizing a live, single replication virus that has a portion of the M2 segment deleted. This innovative approach allows for effective prevention of influenza and supports healthcare professionals in controlling potential pandemics. The company is actively engaged in clinical-stage vaccine development to address both seasonal influenza and emerging respiratory threats.

Invenra Inc. is a biotechnology company based in Madison, Wisconsin, founded in 2011. The company specializes in discovering and developing biologics, particularly antibodies and their derivatives. Invenra employs a unique drug discovery platform that integrates cell-free expression technology with extreme miniaturization, allowing for the screening of a vast number of full-length antibodies in phenotypic assays. This innovative approach enables the identification and optimization of human multi-specific antibodies for therapeutic applications, including treatments for cancer, Alzheimer's disease, and diabetes. Invenra's team consists of experienced scientists with expertise in genomics, biochemistry, and bioengineering, blending advanced research with practical applications in the development of new biologic drugs.

NeuWave Medical, founded in 2004 and headquartered in Madison, Wisconsin, specializes in the development of energy-based minimally invasive medical devices designed to treat various serious medical conditions. The company's founders, both engineers and physician-scientists, leverage their expertise to identify clinical needs and create effective solutions that prioritize safety and efficacy. NeuWave Medical aims to produce high-quality devices that are preferred by leading physicians and medical centers globally.

Sitka Salmon Shares is a community-supported fishery delivering premium, blast-frozen, wild seafood shares to members in the lower 48. It connects its collective of 20 small boat family fishermen-owners with their over 5,000 member Community Supported Fishery and network of regional partners.

Swallow Solutions, LLC is a company based in Madison, Wisconsin, dedicated to addressing swallowing disorders, also known as dysphagia, in the United States. Established in 2004, the company specializes in therapeutic devices designed for the diagnosis and treatment of swallowing difficulties, along with nutritional food products tailored to the specific needs of patients based on their condition. One of its primary offerings is SwallowSTRONG, which includes a custom-molded mouthpiece and accompanying software that aids speech language pathologists in implementing evidence-based therapy to strengthen the tongue. Additionally, the SwallowSTRONG Management System is a cloud-based platform that allows clinicians to monitor patient progress remotely, adjust therapy parameters as needed, and access therapy data for analysis and reporting. Through these innovative solutions, Swallow Solutions aims to enhance the health and well-being of individuals with dysphagia.

Madison Vaccines, Inc. is a biopharmaceutical company based in the United States that specializes in developing therapeutic plasmid DNA vaccines targeting prostate cancer and bone metastases. The company is focused on creating two distinct vaccines designed for patients with prostate cancer, along with a diagnostic test aimed at identifying those who would benefit most from these therapies. Madison Vaccines' immune-activating therapies work by stimulating the immune system to eliminate residual tumor cells, thereby preventing the progression to bone metastases and delaying the need for more invasive treatments such as castration therapies. This approach aims to improve patient outcomes and enhance quality of life by facilitating earlier interventions in the cancer treatment process.

Phoenix, LLC specializes in designing and manufacturing advanced nuclear and particle accelerator technologies, with a focus on high-yield neutron generators. These generators serve diverse applications, including neutron radiography, cargo screening, explosives detection, special nuclear material detection, and medical isotope production. The company also produces compact neutron generators used for nuclear fuel scanning and fast neutron radiography. Founded in 2005 and located in Madison, Wisconsin, Phoenix aims to commercialize nuclear technologies for practical uses across various sectors, including aerospace, defense, medical, and semiconductor industries. Additionally, the company is committed to its long-term vision of developing clean fusion energy solutions.

Ultravisual is a visual network that facilitates inspiration, expression, and collaboration among users. The company aims to enhance visual communication, enabling individuals to share their personal experiences through still and moving imagery. By focusing on the aesthetics of everyday content, Ultravisual transforms ordinary sharing into visually appealing experiences. Based in Brooklyn, New York, the platform offers an organized way for users to share information and connect with others based on their interests, leveraging mobile technology to adapt to the evolving social landscape.

Silatronix, Inc. specializes in the development of organosilicon (OS) compounds and formulations for use in energy storage devices, particularly in rechargeable and non-rechargeable lithium-ion batteries. Founded in 2007 and based in Madison, Wisconsin, the company focuses on creating patented materials that enhance battery performance by extending cell life, increasing capacity, and allowing higher charge voltages. Silatronix's technology combines expertise in organosilicon compounds and nanostructured electrodes, making its products suitable for a variety of applications, including portable electronics, electric vehicles, and utility-scale energy storage. The company's innovations support advancements in battery technology, contributing to more efficient and effective energy solutions.

Phoenix, LLC specializes in designing and manufacturing advanced nuclear and particle accelerator technologies, with a focus on high-yield neutron generators. These generators serve diverse applications, including neutron radiography, cargo screening, explosives detection, special nuclear material detection, and medical isotope production. The company also produces compact neutron generators used for nuclear fuel scanning and fast neutron radiography. Founded in 2005 and located in Madison, Wisconsin, Phoenix aims to commercialize nuclear technologies for practical uses across various sectors, including aerospace, defense, medical, and semiconductor industries. Additionally, the company is committed to its long-term vision of developing clean fusion energy solutions.

FluGen, Inc. is a biopharmaceutical company focused on the prevention and treatment of influenza and other respiratory pathogens. Founded in 2007 and based in Madison, Wisconsin, FluGen develops vaccines to combat seasonal and pandemic influenza. Its primary product, RedeeFlu, is a nasal spray vaccine designed to protect against influenza, utilizing a live, single replication virus that has a portion of the M2 segment deleted. This innovative approach allows for effective prevention of influenza and supports healthcare professionals in controlling potential pandemics. The company is actively engaged in clinical-stage vaccine development to address both seasonal influenza and emerging respiratory threats.

Madison Vaccines, Inc. is a biopharmaceutical company based in the United States that specializes in developing therapeutic plasmid DNA vaccines targeting prostate cancer and bone metastases. The company is focused on creating two distinct vaccines designed for patients with prostate cancer, along with a diagnostic test aimed at identifying those who would benefit most from these therapies. Madison Vaccines' immune-activating therapies work by stimulating the immune system to eliminate residual tumor cells, thereby preventing the progression to bone metastases and delaying the need for more invasive treatments such as castration therapies. This approach aims to improve patient outcomes and enhance quality of life by facilitating earlier interventions in the cancer treatment process.

Swallow Solutions, LLC is a company based in Madison, Wisconsin, dedicated to addressing swallowing disorders, also known as dysphagia, in the United States. Established in 2004, the company specializes in therapeutic devices designed for the diagnosis and treatment of swallowing difficulties, along with nutritional food products tailored to the specific needs of patients based on their condition. One of its primary offerings is SwallowSTRONG, which includes a custom-molded mouthpiece and accompanying software that aids speech language pathologists in implementing evidence-based therapy to strengthen the tongue. Additionally, the SwallowSTRONG Management System is a cloud-based platform that allows clinicians to monitor patient progress remotely, adjust therapy parameters as needed, and access therapy data for analysis and reporting. Through these innovative solutions, Swallow Solutions aims to enhance the health and well-being of individuals with dysphagia.

Silatronix, Inc. specializes in the development of organosilicon (OS) compounds and formulations for use in energy storage devices, particularly in rechargeable and non-rechargeable lithium-ion batteries. Founded in 2007 and based in Madison, Wisconsin, the company focuses on creating patented materials that enhance battery performance by extending cell life, increasing capacity, and allowing higher charge voltages. Silatronix's technology combines expertise in organosilicon compounds and nanostructured electrodes, making its products suitable for a variety of applications, including portable electronics, electric vehicles, and utility-scale energy storage. The company's innovations support advancements in battery technology, contributing to more efficient and effective energy solutions.

SOLOMO Technology Inc. specializes in indoor location intelligence and personalized marketing solutions for retailers. The company offers the SOLOMO Exchange, a web-services platform that integrates with retailers' mobile applications to collect customer identity and location data, facilitating personalized offers while prioritizing customer control over their information. Its suite of tools includes SOLOMO Geo, which provides location-based notifications and usage reports, and SOLOMO Identity, enabling customers to manage their data. Additionally, SOLOMO offers Single Sign On for secure authentication and SOLOMO Intent for users to communicate their intentions to trusted organizations. The company also develops branded in-store mobile applications that enhance customer engagement and assist sales associates in providing better service. Founded in 2010 and based in Madison, Wisconsin, SOLOMO Technology focuses on delivering effective mobile solutions that enhance the retail experience while fostering customer trust.

Swallow Solutions, LLC is a company based in Madison, Wisconsin, dedicated to addressing swallowing disorders, also known as dysphagia, in the United States. Established in 2004, the company specializes in therapeutic devices designed for the diagnosis and treatment of swallowing difficulties, along with nutritional food products tailored to the specific needs of patients based on their condition. One of its primary offerings is SwallowSTRONG, which includes a custom-molded mouthpiece and accompanying software that aids speech language pathologists in implementing evidence-based therapy to strengthen the tongue. Additionally, the SwallowSTRONG Management System is a cloud-based platform that allows clinicians to monitor patient progress remotely, adjust therapy parameters as needed, and access therapy data for analysis and reporting. Through these innovative solutions, Swallow Solutions aims to enhance the health and well-being of individuals with dysphagia.

Celleration Inc. is a medical device company based in Eden Prairie, Minnesota, founded in 1999. The company specializes in developing and commercializing therapeutic ultrasound technologies for wound care. Its flagship product, the MIST Therapy System, employs low-frequency ultrasound delivered through a saline mist to promote healing by penetrating the wound bed and stimulating cellular activity. Unlike traditional wound treatments, which primarily address the surface, MIST Therapy targets deeper layers to enhance the healing process. Celleration received FDA clearance for this therapy in 2005 and has successfully introduced it to the U.S. market, demonstrating significant clinical and economic benefits across numerous healthcare facilities. To date, over one million MIST Therapy treatments have been administered, positively impacting the lives of more than 65,000 patients. The company operates as a subsidiary of Alliqua BioMedical, Inc.

TermSync is an accounts receivable automation platform based in Madison, Wisconsin. The company specializes in managing payment term relationships, currently overseeing over 2,000 such relationships between clients and their customers, with a notable performance of over 99% of payments made on or before the due date. TermSync's offerings include a range of receivable software solutions, featuring services like payment plans, payment options, payment assurance, early pay discounts, and a streamlined credit application process. These tools aim to enhance efficiency in managing receivables and improving cash flow for businesses.